Benefit Absence of Therapeutic Moderate Hypothermia in the Treatment of Cardiac Arrest: A Systematic Review and Meta-Analysis

García García Miguel Ángel; Rosero Arenas María de los Ángeles; Pérez Lluna Leticia; Martínez Cornejo Alfonso; Arizo León David

doi:doi:10.11648/j.ccr.20180202.13

Benefit Absence of Therapeutic Moderate Hypothermia in the Treatment of Cardiac Arrest: A Systematic Review and Meta-Analysis

García García Miguel Ángel, Rosero Arenas María de los Ángeles, Pérez Lluna Leticia, Martínez Cornejo Alfonso, Arizo León David

Published in Cardiology and Cardiovascular Research (Volume 2, Issue 2)

Received: 10 August 2018 Accepted: 30 August 2018 Published: 25 September 2018

Views: Downloads:

Download PDF

Share This Article

Twitter
Linked In
Facebook

Abstract

Background: Hyperthermia is frequent after cardiac arrest, and is associated with poor vital and neurological prognosis. In the last few years there have been published some studies that show benefits with moderate hypothermia in these patients, and other studies haven´t shown such benefits. Aim: To collect all clinical trials evaluating the utility of moderate therapeutic hypothermia in survivors of a cardiac arrest. Method: A comprehensive search of clinical trials evaluating moderate hypothermia in patients who survive a cardiac arrest was carried out. The mortality and quality of life of the survivors were evaluated. The quality of the included studies, the publication bias and the heterogeneity of the results were evaluated. Results: there is no significant reduction in mortality (RR 0.97, 95% CI 0.93-1.01) or increase in quality of life (RR 1.07, 95% CI 0.94-1.21) of the patients undergoing moderate hypothermia versus those not treated with that. There are no different results in patients with cardiac arrest with defibrillable and non – defibrillable rhythms, with the different used cooling methods, or even with the induction of intra – cardiac arrest hypothermia. The mortality of these patients is high, and there are no significant differences in relation to the age or sex of them. Conclusion: In patients who survive a cardiac arrest, the induction of moderate hypothermia is not recommended.

Published in	Cardiology and Cardiovascular Research (Volume 2, Issue 2)
DOI	10.11648/j.ccr.20180202.13
Page(s)	29-48
Creative Commons	This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright	Copyright © The Author(s), 2024. Published by Science Publishing Group

Keywords

Therapeutic Hypothermia, Cardiac Arrest, Mortality, Survival with Good Neurological Prognosis

References

[1]	Cardiac arrest MESH definition. Web: https://www.ncbi.nlm.nih.gov/mesh/?term=cardiac+arrest
[2]	De Vreede-Swagemakers JJ, Gorgels AP, Dubois-Arbouw WI et al. Out-of-hospital cardiac arrest in the 1900´s: a population-based study in the Maastricht area on incidence, characteristics and survival. J Am Coll Cardiol 1997; 30: 1500 – 5.
[3]	Gräsner JT, Bossaert L. Epidemiology and managaement of cardiac arrest: what registries are revealing. Best Pract Res Clin Anaesthesiol. 2013; 27(3):293-306.
[4]	Ocen D, Kalungi S, Ejoku J et al. Prevalence, outcomes and factors associated with adult in hospital cardiac arrests in a low-income country tertiary hospital: a prospective observational study. BMC Emergency Medicine (2015) 15:23.
[5]	Web: http://www.cercp.org/noticias/noticias-del-cercp/345-recomendaciones-erc-2015 Apartado: Declaración del CERCP sobre las nuevas recomendaciones 2015 del European Resuscitation Council (ERC).
[6]	Takino M, Okada Y. Hyperthermia following cardiopulmonary resuscitation. Intensive Care Medicine 1991; 17:419-20.
[7]	Froehler MT, Geocadin RG. Hypothermia for neuroprotection after cardiac arrest: mechanisms, clinical trials and patient care. J Neurol Sci 2007; 261:118-26.
[8]	Hypothermia after Cardiac Arrest Study Group. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. The New England Journal of Medicine 2002; 346:549-56.
[9]	Bernard SA, Gray TW, Buist MD, et al. Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. The New England Journal of Medicine 2002; 346:557-63.
[10]	Nolan JP, Morley PT, Vanden Hoek TL et al. Therapeutic hypothermia after cardiac arrest. An advisory statement by the Advancement Life support Task Force of the International Liaison committee on Resuscitation. Resuscitation 2003; 57:231-5.
[11]	Nielsen N, Wetterslev J, Cronberg T et al. Targeted temperatura management at 33ºC versus 36ºC after cardiac arrest. The New England Journal of Medicine 2013; 369: 2197 – 2206.
[12]	Monsieurs KG, Nolan JP, Bossaert LL et al. European Resuscitation Council Guidelines for Resuscitation 2015. Section A. Executive summary. Resuscitation 2015; 95: 1-80.
[13]	Urrutia G, Bonfill X. Declaración PRISMA: una propuesta para mejorar la publicación de revisiones sistemáticas y metaanálisis. Med Clin 2010; 135: 507-11.
[14]	Ajam K, Gold LS, Beck SS et al. Reliability of the Cerebral Performance Category to classify neurological status among survivors of ventricular fibrillation arrest: a cohort study. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 2011; 19: 38.
[15]	Bonita R, Beaglehole R. Modification of Rankin Scale: Recovery of motor function after stroke. Stroke 1988;19:1497-1500.
[16]	Assessing risk of bias in included studies. Cochrane methods bias. Web: http://methods.cochrane.org/bias/assessing-risk-bias-included-studies
[17]	Jadad AR, Moore RA, Carroll D et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996; 17: 1-12.
[18]	Mori K, Takeyama Y, Itoh Y et al. A multivariate analysis of prognosis factors in survivors of out-of-hospital cardiac arrest with brain hypothermia therapy. Crit Care Med 2000; 28 (Suppl): A168 (ABSTRACT)
[19]	Hachimi-Idrissi S, Zizi M, Nguyen DN et al. The evolution of serum astroglial S-100 beta protein in patients with cardiac arrest treated with mild hypothermia. Resuscitation. 2005 Feb;64(2):187-92.
[20]	Laurent I, Adrie C, Vinsonneau C et al. High-volume hemofiltration after out-of-hospital cardiac arrest: a randomized study. J Am Coll Cardiol. 2005 Aug 2;46(3):432-7.
[21]	Kim F, Olsufka M, Longstreth WT Jr et al. Pilot randomized clinical trial of prehospital induction of mild hypothermia in out-of-hospital cardiac arrest patients with a rapid infusion of 4 degrees C normal saline. Circulation. 2007 Jun 19; 115(24):3064-70.
[22]	Kamäräinen A, Virkkunen I, Tenhunen J et al. Prehospital therapeutic hypothermia for comatose survivors of cardiac arrest: a randomized controlled trial. Acta Anaesthesiol Scand. 2009 Aug; 53(7):900-7.
[23]	Bernard SA, Smith K, Cameron P et al. Rapid Infusion of Cold Hartmanns (RICH) Investigators. Induction of therapeutic hypothermia by paramedics after resuscitation from out-of-hospital ventricular fibrillation cardiac arrest: a randomized controlled trial. Circulation. 2010 Aug 17; 122(7):737-42.
[24]	Castren M, Nordberg P, Svensson L et al. Intra-arrest transnasal evaporative cooling: a randomized, prehospital, multicenter study (PRINCE: Pre-ROSC IntraNasal Cooling Effectiveness). Circulation. 2010 Aug 17; 122(7):729-36.
[25]	Petrovic M, Panic G, Jovelic A et al. Therapeutic hypothermia and neurological outcome after cardiac arrest. Vojnosanitetski Pregled 2011; 68: 495 – 99.
[26]	Bernard SA, Smith K, Cameron P et al. Rapid Infusion of Cold Hartmanns Investigators. Induction of prehospital therapeutic hypothermia after resuscitation from nonventricular fibrillation cardiac arrest*. Crit Care Med. 2012 Mar; 40(3):747-53.
[27]	Debaty G, Maignan M, Savary D et al. Impact of intra-arrest therapeutic hypothermia in outcomes of prehospital cardiac arrest: a randomized controlled trial. Intensive Care Med. 2014 Dec; 40(12):1832-42.
[28]	Kim F, Nichol G, Maynard C et al. Effect of prehospital induction of mild hypothermia on survival and neurological status among adults with cardiac arrest: a randomized clinical trial. JAMA. 2014 Jan 1; 311(1):45-52.
[29]	Pang PY, Wee GH, Hoo AE et al. Therapeutic hypothermia in adult patients receiving extracorporeal life support: early results of a randomized controlled study. J Cardiothorac Surg. 2016 Apr 5; 11:43.
[30]	Bernard SA, Smith K, Finn J et al. Induction of therapeutic hypothermia during out-of-hospital cardiac arrest using a rapid infusion of cold saline. The RINSE trial (Rapid Infusion of Cold Normal Saline). Circulation 2016; 134: 797 – 805.
[31]	Belohlavek J, Smid O, Franek O et al. Hyperinvasive approach prolongs the time window for favorable outcomes in refractory out-of-hospital cardiac arrest: A preliminary analysis of the “Prague OHCA Study”. Resuscitation 2016; 1065: e5.
[32]	Scales DC, Cheskes çs, Verbeekk PR et al. Prehospital cooling to improve successful targeted temperature management after cardiac arrest: a randomized controlled trial. Resuscitation 2017; 121: 187 – 94.
[33]	Lau J, Animan E, Jiménez-Silva K et al. Cumulative meta-analysis of therapeutic trials for myocardial infarction. N Engl J Med 1992; 327: 248 – 54.
[34]	García García MA, Rosero Arenas MA, Ruiz Granell R et al. Cardiac resynchronization effectiveness in the treatment of symptomatic heart failure. Systematic review and meta-analysis. Avances Cardiol 2015; 35 (2): 67 – 75.
[35]	Lascarrou JB, Meziani F, Le Gouge A et al. Therapeutic hypothermia after nonshockable cardiac arrest: the HYPERION multicenter, randomized, controlled, assessor-blinded superiority trial. Scandinavian J of Trauma, Resuscitation and Emergency Medicine 2015; 23: 26.
[36]	Nordberg P, Taccone FS, Castren M et al. Design of the PRINCESS trial: pre-hospital resuscitation intra-nasal cooling effectiveness survival study (PRINCESS). BMC Emergency Medicine 2013; 13: 21.

Cite This Article

Plain Text BibTeX RIS

APA Style

García García Miguel Ángel, Rosero Arenas María de los Ángeles, Pérez Lluna Leticia, Martínez Cornejo Alfonso, Arizo León David. (2018). Benefit Absence of Therapeutic Moderate Hypothermia in the Treatment of Cardiac Arrest: A Systematic Review and Meta-Analysis. Cardiology and Cardiovascular Research, 2(2), 29-48. https://doi.org/10.11648/j.ccr.20180202.13

Copy | Download

ACS Style

García García Miguel Ángel; Rosero Arenas María de los Ángeles; Pérez Lluna Leticia; Martínez Cornejo Alfonso; Arizo León David. Benefit Absence of Therapeutic Moderate Hypothermia in the Treatment of Cardiac Arrest: A Systematic Review and Meta-Analysis. Cardiol. Cardiovasc. Res. 2018, 2(2), 29-48. doi: 10.11648/j.ccr.20180202.13

Copy | Download

AMA Style

García García Miguel Ángel, Rosero Arenas María de los Ángeles, Pérez Lluna Leticia, Martínez Cornejo Alfonso, Arizo León David. Benefit Absence of Therapeutic Moderate Hypothermia in the Treatment of Cardiac Arrest: A Systematic Review and Meta-Analysis. Cardiol Cardiovasc Res. 2018;2(2):29-48. doi: 10.11648/j.ccr.20180202.13

Copy | Download

@article{10.11648/j.ccr.20180202.13,
  author = {García García Miguel Ángel and Rosero Arenas María de los Ángeles and Pérez Lluna Leticia and Martínez Cornejo Alfonso and Arizo León David},
  title = {Benefit Absence of Therapeutic Moderate Hypothermia in the Treatment of Cardiac Arrest: A Systematic Review and Meta-Analysis},
  journal = {Cardiology and Cardiovascular Research},
  volume = {2},
  number = {2},
  pages = {29-48},
  doi = {10.11648/j.ccr.20180202.13},
  url = {https://doi.org/10.11648/j.ccr.20180202.13},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ccr.20180202.13},
  abstract = {Background: Hyperthermia is frequent after cardiac arrest, and is associated with poor vital and neurological prognosis. In the last few years there have been published some studies that show benefits with moderate hypothermia in these patients, and other studies haven´t shown such benefits. Aim: To collect all clinical trials evaluating the utility of moderate therapeutic hypothermia in survivors of a cardiac arrest. Method: A comprehensive search of clinical trials evaluating moderate hypothermia in patients who survive a cardiac arrest was carried out. The mortality and quality of life of the survivors were evaluated. The quality of the included studies, the publication bias and the heterogeneity of the results were evaluated. Results: there is no significant reduction in mortality (RR 0.97, 95% CI 0.93-1.01) or increase in quality of life (RR 1.07, 95% CI 0.94-1.21) of the patients undergoing moderate hypothermia versus those not treated with that. There are no different results in patients with cardiac arrest with defibrillable and non – defibrillable rhythms, with the different used cooling methods, or even with the induction of intra – cardiac arrest hypothermia. The mortality of these patients is high, and there are no significant differences in relation to the age or sex of them. Conclusion: In patients who survive a cardiac arrest, the induction of moderate hypothermia is not recommended.},
 year = {2018}
}

Copy | Download

TY  - JOUR
T1  - Benefit Absence of Therapeutic Moderate Hypothermia in the Treatment of Cardiac Arrest: A Systematic Review and Meta-Analysis
AU  - García García Miguel Ángel
AU  - Rosero Arenas María de los Ángeles
AU  - Pérez Lluna Leticia
AU  - Martínez Cornejo Alfonso
AU  - Arizo León David
Y1  - 2018/09/25
PY  - 2018
N1  - https://doi.org/10.11648/j.ccr.20180202.13
DO  - 10.11648/j.ccr.20180202.13
T2  - Cardiology and Cardiovascular Research
JF  - Cardiology and Cardiovascular Research
JO  - Cardiology and Cardiovascular Research
SP  - 29
EP  - 48
PB  - Science Publishing Group
SN  - 2578-8914
UR  - https://doi.org/10.11648/j.ccr.20180202.13
AB  - Background: Hyperthermia is frequent after cardiac arrest, and is associated with poor vital and neurological prognosis. In the last few years there have been published some studies that show benefits with moderate hypothermia in these patients, and other studies haven´t shown such benefits. Aim: To collect all clinical trials evaluating the utility of moderate therapeutic hypothermia in survivors of a cardiac arrest. Method: A comprehensive search of clinical trials evaluating moderate hypothermia in patients who survive a cardiac arrest was carried out. The mortality and quality of life of the survivors were evaluated. The quality of the included studies, the publication bias and the heterogeneity of the results were evaluated. Results: there is no significant reduction in mortality (RR 0.97, 95% CI 0.93-1.01) or increase in quality of life (RR 1.07, 95% CI 0.94-1.21) of the patients undergoing moderate hypothermia versus those not treated with that. There are no different results in patients with cardiac arrest with defibrillable and non – defibrillable rhythms, with the different used cooling methods, or even with the induction of intra – cardiac arrest hypothermia. The mortality of these patients is high, and there are no significant differences in relation to the age or sex of them. Conclusion: In patients who survive a cardiac arrest, the induction of moderate hypothermia is not recommended.
VL  - 2
IS  - 2
ER  -

Copy | Download

Author Information

García García Miguel Ángel
Rosero Arenas María de los Ángeles
Pérez Lluna Leticia

Internal Medicine Department, Hospital de Sagunto, Valencia, Spain
Martínez Cornejo Alfonso

ICU Department, Hospital de Sagunto, Valencia, Spain
Arizo León David

ICU Department, Hospital de Sagunto, Valencia, Spain

Download PDF

Sections

Plain Text BibTeX RIS

APA Style

García García Miguel Ángel, Rosero Arenas María de los Ángeles, Pérez Lluna Leticia, Martínez Cornejo Alfonso, Arizo León David. (2018). Benefit Absence of Therapeutic Moderate Hypothermia in the Treatment of Cardiac Arrest: A Systematic Review and Meta-Analysis. Cardiology and Cardiovascular Research, 2(2), 29-48. https://doi.org/10.11648/j.ccr.20180202.13

Copy | Download

ACS Style

García García Miguel Ángel; Rosero Arenas María de los Ángeles; Pérez Lluna Leticia; Martínez Cornejo Alfonso; Arizo León David. Benefit Absence of Therapeutic Moderate Hypothermia in the Treatment of Cardiac Arrest: A Systematic Review and Meta-Analysis. Cardiol. Cardiovasc. Res. 2018, 2(2), 29-48. doi: 10.11648/j.ccr.20180202.13

Copy | Download

AMA Style

García García Miguel Ángel, Rosero Arenas María de los Ángeles, Pérez Lluna Leticia, Martínez Cornejo Alfonso, Arizo León David. Benefit Absence of Therapeutic Moderate Hypothermia in the Treatment of Cardiac Arrest: A Systematic Review and Meta-Analysis. Cardiol Cardiovasc Res. 2018;2(2):29-48. doi: 10.11648/j.ccr.20180202.13

Copy | Download

@article{10.11648/j.ccr.20180202.13,
  author = {García García Miguel Ángel and Rosero Arenas María de los Ángeles and Pérez Lluna Leticia and Martínez Cornejo Alfonso and Arizo León David},
  title = {Benefit Absence of Therapeutic Moderate Hypothermia in the Treatment of Cardiac Arrest: A Systematic Review and Meta-Analysis},
  journal = {Cardiology and Cardiovascular Research},
  volume = {2},
  number = {2},
  pages = {29-48},
  doi = {10.11648/j.ccr.20180202.13},
  url = {https://doi.org/10.11648/j.ccr.20180202.13},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ccr.20180202.13},
  abstract = {Background: Hyperthermia is frequent after cardiac arrest, and is associated with poor vital and neurological prognosis. In the last few years there have been published some studies that show benefits with moderate hypothermia in these patients, and other studies haven´t shown such benefits. Aim: To collect all clinical trials evaluating the utility of moderate therapeutic hypothermia in survivors of a cardiac arrest. Method: A comprehensive search of clinical trials evaluating moderate hypothermia in patients who survive a cardiac arrest was carried out. The mortality and quality of life of the survivors were evaluated. The quality of the included studies, the publication bias and the heterogeneity of the results were evaluated. Results: there is no significant reduction in mortality (RR 0.97, 95% CI 0.93-1.01) or increase in quality of life (RR 1.07, 95% CI 0.94-1.21) of the patients undergoing moderate hypothermia versus those not treated with that. There are no different results in patients with cardiac arrest with defibrillable and non – defibrillable rhythms, with the different used cooling methods, or even with the induction of intra – cardiac arrest hypothermia. The mortality of these patients is high, and there are no significant differences in relation to the age or sex of them. Conclusion: In patients who survive a cardiac arrest, the induction of moderate hypothermia is not recommended.},
 year = {2018}
}

Copy | Download

TY  - JOUR
T1  - Benefit Absence of Therapeutic Moderate Hypothermia in the Treatment of Cardiac Arrest: A Systematic Review and Meta-Analysis
AU  - García García Miguel Ángel
AU  - Rosero Arenas María de los Ángeles
AU  - Pérez Lluna Leticia
AU  - Martínez Cornejo Alfonso
AU  - Arizo León David
Y1  - 2018/09/25
PY  - 2018
N1  - https://doi.org/10.11648/j.ccr.20180202.13
DO  - 10.11648/j.ccr.20180202.13
T2  - Cardiology and Cardiovascular Research
JF  - Cardiology and Cardiovascular Research
JO  - Cardiology and Cardiovascular Research
SP  - 29
EP  - 48
PB  - Science Publishing Group
SN  - 2578-8914
UR  - https://doi.org/10.11648/j.ccr.20180202.13
AB  - Background: Hyperthermia is frequent after cardiac arrest, and is associated with poor vital and neurological prognosis. In the last few years there have been published some studies that show benefits with moderate hypothermia in these patients, and other studies haven´t shown such benefits. Aim: To collect all clinical trials evaluating the utility of moderate therapeutic hypothermia in survivors of a cardiac arrest. Method: A comprehensive search of clinical trials evaluating moderate hypothermia in patients who survive a cardiac arrest was carried out. The mortality and quality of life of the survivors were evaluated. The quality of the included studies, the publication bias and the heterogeneity of the results were evaluated. Results: there is no significant reduction in mortality (RR 0.97, 95% CI 0.93-1.01) or increase in quality of life (RR 1.07, 95% CI 0.94-1.21) of the patients undergoing moderate hypothermia versus those not treated with that. There are no different results in patients with cardiac arrest with defibrillable and non – defibrillable rhythms, with the different used cooling methods, or even with the induction of intra – cardiac arrest hypothermia. The mortality of these patients is high, and there are no significant differences in relation to the age or sex of them. Conclusion: In patients who survive a cardiac arrest, the induction of moderate hypothermia is not recommended.
VL  - 2
IS  - 2
ER  -

Copy | Download